All Medicines
Dr. Aditya Singh

Medically Reviewed By

Dr. Aditya Singh, MBBS, MD (Pharmacology)

Reg No: MCI-654321 • Verified Medical Reviewer

Ophthalmologicals

Ryjunea

(atropine sulfate)

Uses, side effects, dosage information & price range

Santen Oy

About this medicine

Ryjunea is indicated for slowing the progression of myopia in paediatric patients. Treatment may be initiated in children aged 3-14 years with a progression rate of 0.5 D or more per year and a severity of -0.5 D to -6.0 D.

Common Substitutes & Alternatives

These medicines share the same salt composition or therapeutic category and can be used as substitutes under professional medical supervision.

VislyfaComposition: ranibizumabLupin Europe GmbH
Price on RequestView Details →
LucentisComposition: ranibizumabNovartis Europharm Limited
Price on RequestView Details →
AfivegComposition: afliberceptSTADA Arzneimittel AG
Price on RequestView Details →
BeovuComposition: brolucizumabNovartis Europharm Limited
Price on RequestView Details →
RanluspecComposition: ranibizumabLupin Europe GmbH
Price on RequestView Details →

Key Information

Salt / Composition

atropine sulfate

Category

Ophthalmologicals

Manufacturer

Santen Oy

Need a doctor's consultation?

Don't self-medicate. Consult a doctor before taking any medicine.

Medical Disclaimer

This information is for educational purposes only and is not a substitute for professional medical advice. Always consult your doctor or pharmacist before taking any medication. Prices are indicative and may vary. Do not start, stop, or change the dosage of any medicine without your doctor's approval.

Disclaimer:Content on this page is for informational purposes only. Do not consume prescription medication without a registered practitioner's direct oversight.